ArticleJournal of immunology (Baltimore, Md. : 1950)2025
LAG3+ CD8+ T cell subset drives HR+/HER2- breast cancer reduction in bispecific antibody armed activated T cell therapy.
Robert Weldon Barnes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.